Intersect ENT
Latest round
- Series D
Last raised
- Feb 2013
Total raised
- $82M
Investors
- 6
About Intersect ENT
Intersect ENT Inc. is a medical technology firm dedicated to addressing ENT-related health issues. Founded in 2003 and headquartered in Menlo Park, California, the company has undergone significant growth since its inception.55 mn. The company has completed 11 deals in total, with the most recent deal occurring on June 2, 2015.Intersect ENT Inc. offers the PROPEL™ sinus implant, a device designed for surgical patients aged 18 and older. This implant helps maintain sinus patency while delivering mometasone furoate, a corticosteroid, directly to the sinus mucosa post-surgery. The PROPEL™ product line includes the PROPEL™, PROPEL™ Mini, and PROPEL™ Contour, each tailored for different sinus anatomies.In 2021, Intersect ENT Inc.55 mn for business expansion and market approach initiatives. Intersect ENT Inc. aims to introduce new products targeting chronic sinusitis within the next 12 months while pursuing entry into additional geographic markets across Europe and Asia by 2024. This strategic growth will enhance its presence in the medical technology sector.
Who invested in Intersect ENT
6 investors across 6 rounds
See all investors in Intersect ENT
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Intersect ENT
Who invested in Intersect ENT?
Intersect ENT has 6 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Intersect ENT raised?
Intersect ENT has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Intersect ENT last raise money?
Intersect ENT's most recent round on record is a Series D, in Feb 2013.
What does Intersect ENT do?
Intersect ENT is a medical devices & equipment company.
Where is Intersect ENT headquartered?
Intersect ENT is headquartered in Menlo Park, US.
Which VCs invest in companies like Intersect ENT?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Intersect ENT's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series D
Raising like Intersect ENT? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.